X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
cardiovascular (141) 141
humans (131) 131
index medicus (131) 131
cardiac & cardiovascular systems (128) 128
heart failure (119) 119
female (107) 107
male (106) 106
aged (102) 102
mortality (101) 101
abridged index medicus (88) 88
middle aged (66) 66
cardiac patients (64) 64
hospitalization (53) 53
aged, 80 and over (51) 51
heart attacks (51) 51
heart failure - mortality (48) 48
heart failure - therapy (48) 48
hospitals (46) 46
united states - epidemiology (46) 46
patients (43) 43
drug therapy (39) 39
registries (39) 39
medical colleges (38) 38
medicare (38) 38
treatment outcome (38) 38
retrospective studies (37) 37
outcomes (32) 32
patient outcomes (31) 31
united states (30) 30
article (29) 29
cardiovascular disease (28) 28
heart (28) 28
heart failure - physiopathology (28) 28
prognosis (28) 28
acute disease (27) 27
follow-up studies (26) 26
medical research (26) 26
care and treatment (25) 25
medicine, experimental (25) 25
heart failure - drug therapy (24) 24
internal medicine (24) 24
analysis (22) 22
association (22) 22
cardiology and cardiovascular medicine (22) 22
guidelines (22) 22
risk factors (22) 22
heart failure - diagnosis (21) 21
heart failure - epidemiology (21) 21
time factors (21) 21
hospital mortality (19) 19
management (19) 19
risk (19) 19
risk assessment (19) 19
care (18) 18
clinical trials (17) 17
patient readmission - statistics & numerical data (17) 17
survival rate - trends (17) 17
trial (17) 17
cardiology (16) 16
diabetes (16) 16
heart failure - complications (16) 16
practice guidelines as topic (16) 16
prospective studies (16) 16
registry (16) 16
stroke (16) 16
studies (16) 16
survival analysis (16) 16
cohort studies (15) 15
impact (15) 15
confidence intervals (14) 14
disease (14) 14
family medical history (14) 14
heart diseases (14) 14
severity of illness index (14) 14
trends (14) 14
acute coronary syndromes (13) 13
acute myocardial-infarction (13) 13
adult (13) 13
disease progression (13) 13
hospitalization - statistics & numerical data (13) 13
medical care (13) 13
optimize-hf (13) 13
outcome assessment (13) 13
quality management (13) 13
quality of health care (13) 13
stroke volume (13) 13
therapy (13) 13
atrial fibrillation (12) 12
chronic obstructive pulmonary disease (12) 12
clinical outcomes (12) 12
survival (12) 12
variables (12) 12
age (11) 11
heart failure - economics (11) 11
medicare beneficiaries (11) 11
myocardial-infarction (11) 11
natriuretic peptide, brain - blood (11) 11
patient discharge (11) 11
blood pressure (10) 10
comorbidity (10) 10
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


JACC: Heart Failure, ISSN 2213-1779, 2015, Volume 3, Issue 10, pp. 774 - 776
Journal Article
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2016, Volume 68, Issue 17, pp. 1898 - 1907
Journal Article
CMAJ : Canadian Medical Association Journal, ISSN 0820-3946, 5/2008, Volume 178, Issue 10, pp. 1249 - 1251
Journal Article
Journal Article
Heart Failure Clinics, ISSN 1551-7136, 04/2008, Volume 4, Issue 2, pp. 217 - 223
Heart failure is a common and serious disorder affecting more than 5 million patients in the United States. Although clinical trials have shown that several... 
Clinical Trials as Topic | Humans | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Quality of Health Care | Heart Failure - drug therapy
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2017, Volume 120, Issue 1, pp. 98 - 105
Abstract Differences in the clinical course of congestion by underlying ejection fraction (EF) have not been well-characterized in acute heart failure (AHF). A... 
Cardiovascular | DIAGNOSIS | CARDIAC & CARDIOVASCULAR SYSTEMS | MANAGEMENT | TASK-FORCE | CARDIORENAL RESCUE | OUTCOMES | PRESERVED SYSTOLIC FUNCTION | HOSPITALIZATION | STRATEGIES | AHF | Severity of Illness Index | Risk Assessment - methods | United States - epidemiology | Acute Disease | Prognosis | Prospective Studies | Survival Rate - trends | Double-Blind Method | Humans | Middle Aged | Heart Failure - physiopathology | Stroke Volume - physiology | Male | Systole | Hospitalization - trends | Peptide Fragments - blood | Cause of Death - trends | Female | Aged | Heart Failure - diagnosis | Natriuretic Peptide, Brain - blood | Heart Failure - mortality | Heart failure | Heart | Care and treatment | Lung diseases, Obstructive | Analysis | Cardiac patients | Diuretics | Development and progression | Natriuretic peptides | Peptides | Syngeneic grafts | Self evaluation | Body weight | Clinical trials | Beta blockers | Optimization | Visual perception | Dyspnea | Fibrillation | Ischemia | Etiology | Risk assessment | Failure analysis | Xenografts | Flutter | Chronic obstructive pulmonary disease | Diagnosis | Heart diseases | Age | Brain natriuretic peptide | Edema | Evaluation | Signs and symptoms | Vibration | Kidneys | Adjustment | Mortality | Lung diseases | Markers | Hospitalization | Trajectories | Regression analysis | Congestion | Patients | Medical prognosis | Obstructive lung disease | Renal failure | Death | Ejection | Kidney transplantation | acute heart failure | ejection fraction | outcomes | congestion | signs and symptoms
Journal Article
American Heart Journal, ISSN 0002-8703, 2016, Volume 174, pp. 103 - 110
Exenatide once-weekly is an extended release formulation of exenatide, a glucagon-like peptide–1 receptor agonist, which can improve glycemic control, body... 
Cardiovascular | DIABETES-MELLITUS | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | GLUCAGON-LIKE PEPTIDE-1 | MYOCARDIAL-INFARCTION | SAFETY | RECEPTOR AGONISTS | GLUCOSE | CLINICAL-TRIALS | DISEASE | INCRETIN-BASED THERAPIES | Risk Assessment - methods | United States - epidemiology | Glucagon-Like Peptide 1 | Prognosis | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Male | Peptides - administration & dosage | Incidence | Dose-Response Relationship, Drug | Microspheres | Hypoglycemic Agents - administration & dosage | Time Factors | Injections, Subcutaneous | Cardiovascular Diseases - epidemiology | Venoms - administration & dosage | Adult | Female | Diabetes Mellitus, Type 2 - complications | Cardiovascular Diseases - etiology | Survival Rate - trends | Double-Blind Method | Drug Administration Schedule | Risk Factors | China - epidemiology | Diabetes Mellitus, Type 2 - blood | Ontario - epidemiology | Italy - epidemiology | Aged | Blood Glucose - metabolism | Diabetes Mellitus, Type 2 - drug therapy | United Kingdom - epidemiology | Type 2 diabetes | Hypoglycemic agents | Glucagon | Cardiac patients | Heart attack | Corporate sponsorship | Heart attacks | Research & development--R&D | Pragmatism | Cardiovascular disease | Diabetes | Pharmaceutical industry | Patients | Cholesterol
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2015, Volume 66, Issue 23, pp. 2618 - 2629
Abstract Background Patients with moderate-to-severe chronic kidney disease (CKD) are poorly represented in clinical trials of cardiac resynchronization... 
Cardiovascular | Internal Medicine | chronic kidney disease | pacemaker | cardiomyopathy | biventricular | MORTALITY | CARDIAC & CARDIOVASCULAR SYSTEMS | HEART-FAILURE | RENAL-FUNCTION | CARDIAC-RESYNCHRONIZATION THERAPY | Cardiac Resynchronization Therapy - methods | United States - epidemiology | Humans | Medicare - statistics & numerical data | Hospitalization - statistics & numerical data | Male | Electric Countershock - statistics & numerical data | Renal Insufficiency, Chronic - epidemiology | Heart Failure - therapy | Comparative Effectiveness Research | Aged, 80 and over | Female | Renal Insufficiency, Chronic - diagnosis | Heart Failure - diagnosis | Heart Failure - epidemiology | Electric Countershock - methods | Severity of Illness Index | Glomerular Filtration Rate | Comorbidity | Defibrillators, Implantable - statistics & numerical data | Proportional Hazards Models | Cardiac Resynchronization Therapy - statistics & numerical data | Treatment Outcome | Electric Countershock - instrumentation | Survival Analysis | Aged | Heart | Sects | Medical colleges | Heart beat | Chronic kidney failure | Defibrillators | Cardiovascular agents | Medical research | Implants, Artificial | Prosthesis | Medicine, Experimental | Development and progression | Comparative analysis | Confidence intervals | Heart failure | Codes | Medicare | Diagnosis related groups--DRGs | Mortality | Ulcers | Amputation | Population | Hospitalization | Kidney diseases | Dementia
Journal Article
American Heart Journal, ISSN 0002-8703, 2015, Volume 170, Issue 2, pp. 313 - 321.e4
Journal Article